Arena Pharmaceuticals, Inc. Research and Development in Process
Arena Pharmaceuticals, Inc. reported Research and Development in Process of $70.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-02-23
- Arena Pharmaceuticals, Inc. research and development in process for the quarter ending 2021-12-31 was $0.00.
- Arena Pharmaceuticals, Inc. research and development in process for the quarter ending 2021-09-30 was $70.00M.
- Arena Pharmaceuticals, Inc. research and development in process for the quarter ending 2020-12-31 was $0.00.
- Arena Pharmaceuticals, Inc. research and development in process for the quarter ending 2020-09-30 was $0.00.
- Arena Pharmaceuticals, Inc. research and development in process for fiscal 2021 was $70.00M.
- Arena Pharmaceuticals, Inc. research and development in process for fiscal 2020 was $0.00.
- Arena Pharmaceuticals, Inc. research and development in process for fiscal 2019 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $70.00M derived: sum of 2 quarters · filed 2022-02-23 | $70.00M 10-K · filed 2022-02-23 | |
| 2021-09-30 | $70.00M 10-Q · filed 2021-11-04 | $70.00M 10-Q · filed 2021-11-04 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $0.00 derived: sum of 2 quarters · filed 2022-02-23 | $0.00 10-K · filed 2022-02-23 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-02-23 |